Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 21, 2025

Genius Group increases Bitcoin Treasury to 200 Bitcoin, announces accelerated GENIUS Act plans.
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on July 18, 2025 it purchased 20 Bitcoin, increasing its …

Orb Strategies Unveils New Website & Expanded Financial Services
Zurich, Switzerland, July 21, 2025 (GLOBE NEWSWIRE) -- Orb Strategies, the latest name in financial and FinTech consulting, has launched its new website featuring a suite of updated financial services that is more comprehensive than ever. This enhanced …

ESCO Completes Divestiture Of VACCO Industries
St. Louis, July 21, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) completed the previously announced divestiture of VACCO Industries to RBC Bearings Incorporated (NYSE: RBC), an international manufacturer and marketer of highly engineered …

AIXA Miner Releases Upgraded AI-Driven ETH and XRP Cloud Mining Plans for Daily Passive Income
Denver, Colorado, July 21, 2025 (GLOBE NEWSWIRE) -- AIXA Miner today announced the launch of its enhanced Ethereum (ETH) and Ripple (XRP) cloud mining contracts, offering a stable and intelligent alternative to high-volatility trading. Designed for …

Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate principal amount of new …

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
– Results Reflect Continued Financial Strength and Deleveraging – BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced certain unaudited preliminary financial results …

XRP price rises, CJB Crypto one-day mining contract becomes more popular
London, UK, July 21, 2025 (GLOBE NEWSWIRE) -- With the rising prices of mainstream cryptocurrencies such as XRP, ETH and BTC, CJB Crypto has attracted more and more users. In order to meet the needs of users to obtain passive income from digital assets …

Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine’s Protection of Neurons and Synapses in Alzheimer’s Disease
PITTSBURGH, July 21, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, published results of a proteomics analysis from the …

Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the results from a Stepwise Moving Loop, Time Domain Electromagnetic (“SWML- …

Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced it intends to invest an …

Proposed Consolidation of Shares
Vancouver, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces that the Company intends to consolidate the common shares in the capital of the Company (the “Shares”) …

Domestic Metals Begins Trading on OTCQB
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) announces that its common shares have started trading on the OTCQB marketplace, a U.S. marketplace …

NextGen Digital Announces Treasury Strategy to Incorporate Crypto Assets, Acquires $1.0 Million in Bitcoin
Vancouver, B.C., July 21, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform focused on bridging traditional capital markets with Web3 infrastructure, …

Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced updates to its Retina Scientific Advisory Board (SAB) and …

Ambiq Announces Launch of Initial Public Offering
Ambiq Announces Launch of Initial Public Offering AUSTIN, Texas, July 21, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the commencement of its initial …

iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (“iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC (“Concentra”) will …

Digi Power X Announces $15 Million Registered Direct Offering of Common Stock
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. The offering was to a single new fundamental institutional …

ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML Marseille, France, July 21, 2025 – ImCheck …

National Comprehensive Cancer Network® (NCCN®) Guidelines Recommend Monoclonal Antibodies for COVID-19 Prevention in People with Cancer; New Data Published in JAMA Oncology Underscore Severe Impact of COVID-19 on This Population
NCCN Clinical Practice Guidelines in Oncology for the Prevention and Treatment of Cancer-Related Infections now recommend monoclonal antibodies for pre-exposure prophylaxis against COVID-19 in appropriate cancer populations Reflects growing alignment among …

Gilat to Report Second Quarter 2025 Results on Wednesday, August 6th
PETAH TIKVA, Israel, July 21, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its second quarter 2025 …